Cutler Group’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-124	Closed	-$12K	–	5297
2022 Q2	$12K	Sell	124 -400	-76%	-$36.9K	﹤0.01%	3054
2022 Q1	$49K	Buy	524 +318	+154%	+$26.9K	﹤0.01%	2263
2021 Q4	$17K	Buy	206 +163	+379%	+$15K	﹤0.01%	3255
2021 Q3	$4K	Sell	43 -3,557	-99%	-$336K	﹤0.01%	4638
2021 Q2	$350K	Buy	3,600 +3,000	+500%	+$288K	0.02%	957
2021 Q1	$58K	Sell	600 -1,407	-70%	-$148K	﹤0.01%	2236
2020 Q4	$192K	Buy	2,007 +757	+61%	+$73.1K	0.01%	1114
2020 Q3	$120K	Buy	1,250 +850	+213%	+$98.3K	0.01%	1210
2020 Q2	$48K	Buy	+400	New	+$44.2K	﹤0.01%	1780
2019 Q4	–	Sell	-3,900	Closed	-$408K	–	4380
2019 Q3	$351K	Sell	3,900 -4,500	-54%	-$420K	0.03%	470
2019 Q2	$709K	Buy	8,400 +3,607	+75%	+$296K	0.07%	271
2019 Q1	$422K	Sell	4,793 -1,950	-29%	-$163K	0.04%	375
2018 Q4	$481K	Buy	+6,743	New	+$646K	0.05%	343
2018 Q1	–	Sell	-24,801	Closed	-$2.09M	–	4963
2017 Q4	$1.92M	Sell	24,801 -21,670	-47%	-$1.48M	0.08%	179
2017 Q3	$2.85M	Buy	46,471 +37,744	+432%	+$1.99M	0.11%	145
2017 Q2	$401K	Buy	8,727 +7,327	+523%	+$355K	0.01%	823
2017 Q1	$60K	Sell	1,400 -1,987	-59%	-$85.1K	﹤0.01%	2215
2016 Q4	$131K	Buy	3,387 +1,187	+54%	+$53.7K	﹤0.01%	1658
2016 Q3	$111K	Buy	2,200 +1,883	+594%	+$93.8K	0.01%	1720
2016 Q2	$14K	Sell	317 -1,519	-83%	-$69.9K	﹤0.01%	3762
2016 Q1	$72K	Sell	1,836 -4,288	-70%	-$170K	﹤0.01%	1940
2015 Q4	$346K	Buy	+6,124	New	+$311K	0.02%	814